BioCentury
ARTICLE | Politics & Policy

House bill seeks to tweak Orphan Drug Act, could pose threat to pathway

January 29, 2020 1:45 AM UTC
Updated on Jan 31, 2020 at 11:13 PM UTC

A new bill in the U.S. House of Representatives that seeks to limit abuse of the Orphan Drug Act could have the unintended effect of disincentivizing companies from developing therapies for rare diseases, if the proposed amendment of the act is applied more broadly.

The House Committee on Energy & Commerce will hold a hearing to discuss H.R. 4712 on Wednesday. ...